STAT3 and its activators in intestinal defense and mucosal homeostasis

Petr Hruz, Sara Dann-Grice, Lars Eckmann

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose of review: Coordination of innate and adaptive immunity is central to effective mucosal immune defense and homeostasis. The review discusses Recent findings on two cytokines, IL-22 and IL-6, and their common signaling pathway, which bridge innate and adaptive immunity in the intestinal tract. Recent findings: IL-22, a signature product of Th17 cells, is also secreted at functionally significant levels by innate immune cells, especially NKp44/NKp46-expressing natural killer (NK) cells and lymphoid tissue inducer cells after IL-23 stimulation. IL-22 acts primarily on epithelial cells and is overall protective, as its inhibition or loss exacerbates intestinal inflammation. Similarly, IL-6, secreted by macrophages, dendritic cells, epithelial cells, and T cells protects against mucosal damage, but it is also key in the development of Th17 cells, which mediate inflammatory and defensive responses in the intestine. Both cytokines activate STAT3 signaling, whose intestinal activities depend on the specific cell types involved. STAT3 in epithelial and myeloid cells mediates mucosa-protective and anti-inflammatory functions, whereas STAT3 in T cells promotes inflammation. Summary: IL-22 and IL-6 are prime examples of cytokines that coordinate innate and adaptive immune responses in the intestine. They and their common signaling pathway, STAT3 can promote or protect against inflammation indicating that pharmacological manipulation for therapeutic purposes in intestinal inflammatory conditions may present special challenges.

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume26
Issue number2
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Adaptive Immunity
Homeostasis
Innate Immunity
Th17 Cells
Interleukin-6
Epithelial Cells
Cytokines
Inflammation
Intestines
Interleukin-23
T-Lymphocytes
Lymphoid Tissue
Myeloid Cells
Helper-Inducer T-Lymphocytes
Natural Killer Cells
Dendritic Cells
Mucous Membrane
Anti-Inflammatory Agents
Macrophages
Pharmacology

Keywords

  • Inflammation
  • Innate immunity
  • Intestinal tract
  • Mucosal immunology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

STAT3 and its activators in intestinal defense and mucosal homeostasis. / Hruz, Petr; Dann-Grice, Sara; Eckmann, Lars.

In: Current Opinion in Gastroenterology, Vol. 26, No. 2, 03.2010, p. 109-115.

Research output: Contribution to journalArticle

@article{c17d1f409b3e4843a27587a05f86bd0f,
title = "STAT3 and its activators in intestinal defense and mucosal homeostasis",
abstract = "Purpose of review: Coordination of innate and adaptive immunity is central to effective mucosal immune defense and homeostasis. The review discusses Recent findings on two cytokines, IL-22 and IL-6, and their common signaling pathway, which bridge innate and adaptive immunity in the intestinal tract. Recent findings: IL-22, a signature product of Th17 cells, is also secreted at functionally significant levels by innate immune cells, especially NKp44/NKp46-expressing natural killer (NK) cells and lymphoid tissue inducer cells after IL-23 stimulation. IL-22 acts primarily on epithelial cells and is overall protective, as its inhibition or loss exacerbates intestinal inflammation. Similarly, IL-6, secreted by macrophages, dendritic cells, epithelial cells, and T cells protects against mucosal damage, but it is also key in the development of Th17 cells, which mediate inflammatory and defensive responses in the intestine. Both cytokines activate STAT3 signaling, whose intestinal activities depend on the specific cell types involved. STAT3 in epithelial and myeloid cells mediates mucosa-protective and anti-inflammatory functions, whereas STAT3 in T cells promotes inflammation. Summary: IL-22 and IL-6 are prime examples of cytokines that coordinate innate and adaptive immune responses in the intestine. They and their common signaling pathway, STAT3 can promote or protect against inflammation indicating that pharmacological manipulation for therapeutic purposes in intestinal inflammatory conditions may present special challenges.",
keywords = "Inflammation, Innate immunity, Intestinal tract, Mucosal immunology",
author = "Petr Hruz and Sara Dann-Grice and Lars Eckmann",
year = "2010",
month = "3",
doi = "10.1097/MOG.0b013e3283365279",
language = "English (US)",
volume = "26",
pages = "109--115",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - STAT3 and its activators in intestinal defense and mucosal homeostasis

AU - Hruz, Petr

AU - Dann-Grice, Sara

AU - Eckmann, Lars

PY - 2010/3

Y1 - 2010/3

N2 - Purpose of review: Coordination of innate and adaptive immunity is central to effective mucosal immune defense and homeostasis. The review discusses Recent findings on two cytokines, IL-22 and IL-6, and their common signaling pathway, which bridge innate and adaptive immunity in the intestinal tract. Recent findings: IL-22, a signature product of Th17 cells, is also secreted at functionally significant levels by innate immune cells, especially NKp44/NKp46-expressing natural killer (NK) cells and lymphoid tissue inducer cells after IL-23 stimulation. IL-22 acts primarily on epithelial cells and is overall protective, as its inhibition or loss exacerbates intestinal inflammation. Similarly, IL-6, secreted by macrophages, dendritic cells, epithelial cells, and T cells protects against mucosal damage, but it is also key in the development of Th17 cells, which mediate inflammatory and defensive responses in the intestine. Both cytokines activate STAT3 signaling, whose intestinal activities depend on the specific cell types involved. STAT3 in epithelial and myeloid cells mediates mucosa-protective and anti-inflammatory functions, whereas STAT3 in T cells promotes inflammation. Summary: IL-22 and IL-6 are prime examples of cytokines that coordinate innate and adaptive immune responses in the intestine. They and their common signaling pathway, STAT3 can promote or protect against inflammation indicating that pharmacological manipulation for therapeutic purposes in intestinal inflammatory conditions may present special challenges.

AB - Purpose of review: Coordination of innate and adaptive immunity is central to effective mucosal immune defense and homeostasis. The review discusses Recent findings on two cytokines, IL-22 and IL-6, and their common signaling pathway, which bridge innate and adaptive immunity in the intestinal tract. Recent findings: IL-22, a signature product of Th17 cells, is also secreted at functionally significant levels by innate immune cells, especially NKp44/NKp46-expressing natural killer (NK) cells and lymphoid tissue inducer cells after IL-23 stimulation. IL-22 acts primarily on epithelial cells and is overall protective, as its inhibition or loss exacerbates intestinal inflammation. Similarly, IL-6, secreted by macrophages, dendritic cells, epithelial cells, and T cells protects against mucosal damage, but it is also key in the development of Th17 cells, which mediate inflammatory and defensive responses in the intestine. Both cytokines activate STAT3 signaling, whose intestinal activities depend on the specific cell types involved. STAT3 in epithelial and myeloid cells mediates mucosa-protective and anti-inflammatory functions, whereas STAT3 in T cells promotes inflammation. Summary: IL-22 and IL-6 are prime examples of cytokines that coordinate innate and adaptive immune responses in the intestine. They and their common signaling pathway, STAT3 can promote or protect against inflammation indicating that pharmacological manipulation for therapeutic purposes in intestinal inflammatory conditions may present special challenges.

KW - Inflammation

KW - Innate immunity

KW - Intestinal tract

KW - Mucosal immunology

UR - http://www.scopus.com/inward/record.url?scp=77149154668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149154668&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e3283365279

DO - 10.1097/MOG.0b013e3283365279

M3 - Article

VL - 26

SP - 109

EP - 115

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -